Page last updated: 2024-10-20

uracil and Depressive Disorder, Major

uracil has been researched along with Depressive Disorder, Major in 1 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, JJ1
Zhou, CJ1
Liu, Z1
Fu, YY1
Zheng, P1
Yang, DY1
Li, Q1
Mu, J1
Wei, YD1
Zhou, JJ1
Huang, H1
Xie, P1

Other Studies

1 other study available for uracil and Depressive Disorder, Major

ArticleYear
Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Journal of proteome research, 2015, Aug-07, Volume: 14, Issue:8

    Topics: Adult; beta-Alanine; Biomarkers; Bipolar Disorder; Depressive Disorder, Major; Diagnosis, Differenti

2015